European Medicines Agency recognizes potential of lead compound MP1032 in addressing a high unmet medical need in Duchenne Muscular Dystrophy (DMD)

You might also be interested in reading Tom Lee cools on $250K Bitcoin call, year-end ATH now just a ‘maybe’.